Citas bibligráficas
Castro, C., (2020). Antihipertensivos en Covid 19: ¿tratar con inhibidores de la enzima convertidora de angiotensina o evitarlos? [Tesis, Universidad Privada Antenor Orrego - UPAO]. https://hdl.handle.net/20.500.12759/6723
Castro, C., Antihipertensivos en Covid 19: ¿tratar con inhibidores de la enzima convertidora de angiotensina o evitarlos? [Tesis]. : Universidad Privada Antenor Orrego - UPAO; 2020. https://hdl.handle.net/20.500.12759/6723
@misc{renati/381116,
title = "Antihipertensivos en Covid 19: ¿tratar con inhibidores de la enzima convertidora de angiotensina o evitarlos?",
author = "Castro Osorio, Carmen Rosa",
publisher = "Universidad Privada Antenor Orrego - UPAO",
year = "2020"
}
The SARS-CoV-2 virus has as its entry of infection the receptors of the angiotensin converting enzyme 2 (ACE-2). It has been evidenced as a probable risk factor to present high blood pressure and severe COVID-19, however, no guidelines have been established to guide the treatment with antihypertensive drugs of these patients, so a narrative review was conducted using the databases Scopus and Pubmed, through a search strategy, the information was structured on epidemiological aspects, biological plausibility of angiotensin converting enzyme inhibitors (ACEI) and recommendations about treatment of hypertensive patients with COVID-19. Studies show that the risk of SARS-CoV-2 virus infection is increased in patients with high blood pressure due to increased expression of ACE-2 receptors, however, no risk of increased clinical severity is shown, so it is recommended not to discontinue treatment
IMPORTANTE
La información contenida en este registro es de entera responsabilidad de la universidad, institución o escuela de educación superior que administra el repositorio académico digital donde se encuentra el trabajo de investigación y/o proyecto, los cuales son conducentes a optar títulos profesionales y grados académicos. SUNEDU no se hace responsable por los contenidos accesibles a través del Registro Nacional de Trabajos de Investigación – RENATI.